Case Reports

Subscribe to collection
FilterHide Filter
  • Case report
    Open Access

    Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma

    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
    Vol. 5Issue 1p236–240Published online: January 13, 2021
    • Anza Zahid
    • Derek R. Johnson
    • Sani H. Kizilbash
    Cited in Scopus: 0
      A 62-year-old man presented with a history of atypical meningioma (World Health Organization grade II) and recurrent as anaplastic meningioma (World Health Organization grade III). His previous treatments included multiple surgical resections, fractionated radiation therapy, stereotactic radiosurgery, everolimus/octreotide long-acting release, bevacizumab, and hydroxyurea. Magnetic resonance imaging revealed rapid volumetric progression over the prior 9 months, with a near tripling in size from 29.9 cm3 to 80.4 cm3.
      Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma

    The content on this site is intended for healthcare professionals.


    We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
    Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


    RELX